Clinical Usefulness of Aripiprazole and Lamotrigine in Schizoaffective Presentation of Tuberous Sclerosis

키워드

참고문헌 (38)

1. Roach ES, "Diagnosis and management of neurocutaneous syndromes", Semin Neurol, 8, pp.83~96 (1988)
2. Osborne JP, "Epidemiology of tuberous sclerosis", Ann N Y Acad Sci, 615, pp.125~127 (1991)
3. Au KS, "Molecular genetic basis of tuberous sclerosis complex: from bench to bedside", J Child Neurol, 19, pp.699~709 (2004)
4. Leclezio L, "Advances in the treatment of tuberous sclerosis complex", Curr Opin Psychiatry, 28, pp.113~120 (2015)
5. Curatolo P, "Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment", J Child Neurol, 25, pp.873~880 (2010)
6. D'Agati E, "Attentiondeficit hyperactivity disorder (ADHD) and tuberous sclerosis complex", J Child Neurol, 24, pp.1282~1287 (2009)
7. Muzykewicz DA, "Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex", Epilepsy Behav, 11, pp.506~513 (2007)
8. Prather P, "Behavioral and cognitive aspects of tuberous sclerosis complex", J Child Neurol, 19, pp.666~674 (2004)
9. de Vries PJ, "The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families", Eur Child Adolesc Psychiatry, 16, pp.16~24 (2007)
10. Caplan R, "Psychopathology in pediatric complex partial and primary generalized epilepsy", Dev Med Child Neurol, 40, pp.805~811 (1998)
11. Leverich GS, "Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers", Am J Psychiatry, 163, pp.232~239 (2006)
12. Raznahan A, "Psychopathology in tuberous sclerosis: an overview and findings in a population-based sample of adults with tuberous sclerosis", J Intellect Disabil Res, 50, pp.561~569 (2006)
13. Khanna R, "Mania in a five-year-old child with tuberous sclerosis", Br J Psychiatry, 155, pp.117~119 (1989)
14. Hagenah U, "Tuberous sclerosis and organic bipolar disorder in a 15-year-old adolescent", Z Kinder Jugendpsychiatr Psychother, 27, pp.283~289 (1999)
15. Chopra VK, "Bipolar disorder associated with tuberous sclerosis: Chance association or aetiological relationship?", Indian J Psychiatry, 48, pp.66~68 (2006)
16. Haq MZ, "Bipolar disorder and tuberous sclerosis complex: is it a mere coincidence?", CNS Spectr, 14, pp.643~647 (2009)
17. Al-Sharbati M, "A rare presentation of attention deficit", hyperactivity disorder: A recommendation to be more alert!, 2010, pp.10, 84~88
18. Sparagana SP, "Tuberous sclerosis complex", Curr Opin Neurol, 13, pp.115~119 (2000)
19. Qin P, "Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study", BMJ, 331, pp.23~ (2005)
20. Raja M, "Autistic spectrum disorders and schizophrenia in the adult psychiatric setting: diagnosis and comorbidity", Psychiatr Danub, 22, pp.514~521 (2010)
21. Cooper SA, "Psychosis and adults with intellectual disabilities. Prevalence, incidence, and related factors", Soc Psychiatry Psychiatr Epidemiol, 42, pp.530~536 (2007)
22. Munesue T, "High prevalence of bipolar disorder comorbidity in adolescents and young adults with high-functioning autism spectrum disorder: a preliminary study of 44outpatients", J Affect Disord, 111, pp.170~175 (2008)
23. Tamam L, "Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder:prevalence and clinical correlates", Eur Arch Psychiatry Clin Neurosci, 258, pp.385~393 (2008)
24. Daniels RJ, "Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16", Hum Mol Genet, 10, pp.339~352 (2010)
25. de Vries PJ, "Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist", Pediatr Neurol, 52, pp.25~35 (2015)
26. Geddes JR, "Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials", Br J Psychiatry, 194, pp.4~9 (2009)
27. Adityanjee, "Prior neurologic illness and the syndrome of irreversible lithium-effectuated neurotoxicity (SILENT)", Aust N Z J Psychiatry, 23, pp.422~424 (1989)
28. Shepherd CW, "Causes of death in patients with tuberous sclerosis", Mayo Clin Proc, 66, pp.792~796 (1991)
29. Willmore LJ, "Vigabatrin: 2008 update", Epilepsia, 50, pp.163~173 (2009)
30. Tatum WO 4th, "Post-marketing antiepileptic drug survey. Postmarketing experience with topiramate and cognition", Epilepsia, 42, pp.1134~1140 (2001)
31. Lee S, "The effects of adjunctive topiramate on cognitive function in patients with epilepsy", Epilepsia, 44, pp.39~347 (2003)
32. Loring DW, "Cognitive side effects of antiepileptic drugs in children", Neurology, 62, pp.872~877 (2004)
33. Bourgeois B, "New dosages and formulations of AEDs for use in pediatric epilepsy", Neurology, 58(12 Suppl 7), pp.S2~S5 (2002)
34. Pressler RM, "Effect of lamotrigine on cognition in children with epilepsy", Neurology, 66, pp.1495~1499 (2006)
35. Kirino E., "Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents", Adolesc Health Med Ther, 5, pp.211~221 (2014)
36. 오주영, "Comparison of Aripiprazole and Other Atypical Antipsychotics for Pediatric Bipolar Disorder: A Retrospective Chart Review of Efficacy and Tolerability", Clinical Psychopharmacology and Neuroscience, 11(2), pp.72~79 (2013), 대한정신약물학회
37. Jung Goo Lee, "Switching Patients with Chronic Schizophrenia to Aripiprazole: the Improvement in Cognitive Function", Clinical Psychopharmacology and Neuroscience, 4(1), pp.32~39 (2006), 대한정신약물학회
38. Sampson JR, "Therapeutic targeting of mTOR in tuberous sclerosis", Biochem Soc Trans, 37, pp.259~264 (2009)

관련 논문AI추천